Technology Solutions

Kyowa Hakko Kirin joins Certara’s Simcyp consortium

Wednesday, September 13, 2017

Certara, a provider of model-informed drug development and regulatory science, announced that Kyowa Hakko Kirin has joined the Simcyp Consortium and licensed the Simcyp Population-based Simulator. Kyowa Hakko Kirin is the 36th leading biopharmaceutical company and the 11th Japanese pharmaceutical company to join the Consortium. Member companies meet in a pre-competitive environment and work together to progress the evolution of modeling and simulation (M&S) and the Simcyp Simulator.

[Read More]

Science Exchange launches updated enterprise dynamic report tool

Tuesday, September 12, 2017

Demonstrating the company’s commitment to support its clients’ growth plans by optimizing data aggregation and business intelligence, Science Exchange, a secure platform for outsourced research and development (R&D), recently released the latest version of its enterprise dynamic report tool. The tool enables Science Exchange’s enterprise clients, including some of the world’s top pharma and biotech companies, to perform real-time tracking of key performance indicators (KPIs) related to their outsourced R&D investments.

[Read More]

ERT acquires Biomedical Systems

Tuesday, September 12, 2017

ERT, a global data and technology company that minimizes uncertainty and risk in clinical trials, has acquired Biomedical Systems, a well-recognized provider of reliable imaging, as well as cardiac safety and respiratory data collection solutions. Financial terms of the transaction were not disclosed.

[Read More]

ERT launches Express Overread for respiratory clinical trials

Monday, September 11, 2017

ERT, a global data and technology company that minimizes uncertainty and risk in clinical trials, announced the availability of its Express Overread service for clinical trials that require spirometry and pulmonary function testing (PFT). The service provides centralized overread of PFT results in one hour or less, enabling investigative sites to quickly and reliably determine which patients are eligible to be included and randomized in clinical trials.

[Read More]

NantHealth, Asia Genomics expand GPS Cancer in Southeast Asia

Tuesday, September 5, 2017

NantHealth, a next-generation, evidence-based, personalized healthcare company, announced that it has entered into an agreement for GPS Cancer, a proteogenomic molecular test that helps guide treatment strategies including choice of standard chemotherapy for oncologists, with Asia Genomics, a provider and distributor of molecular testing services and key player in the field of personalized medicine in Southeast Asia.

[Read More]

Abbott addresses pacemaker hacking fears

Tuesday, September 5, 2017

On August 23, 2017, the FDA approved a firmware update that is now available and is intended as a recall, specifically a corrective action, to reduce the risk of patient harm due to potential exploitation of cybersecurity vulnerabilities for certain Abbott (formerly St. Jude Medical) pacemakers. “Firmware” is a specific type of software embedded in the hardware of a medical device (e.g. a component in the pacemaker).

[Read More]

LifeArc, AUTM partner on training for scholars in technology transfer

Wednesday, August 30, 2017

LifeArc, the medical research charity formerly known as MRC Technology, has partnered with The Association of University Technology Managers (AUTM) Foundation to offer a competitive program that will provide essential training for scientists seeking a career in life sciences technology transfer. This joint initiative emphasizes the commitment of both organizations to improve access to the technology transfer profession.

[Read More]